 <h1>Olsalazine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to olsalazine: oral capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, olsalazine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking olsalazine:</p><p>
<i>More common</i>
</p><ul>
<li>Agitation</li>
<li>bloody diarrhea</li>
<li>blood in the urine</li>
<li>coma</li>
<li>confusion</li>
<li>dark-colored urine</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dizziness</li>
<li>fever</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>hostility</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>irritability</li>
<li>itching, skin rash</li>
<li>lethargy</li>
<li>light-colored stools</li>
<li>muscle twitching</li>
<li>nausea</li>
<li>pain in the groin or genitals</li>
<li>rapid weight gain</li>
<li>redness or other discoloration of the skin</li>
<li>seizures</li>
<li>severe sunburn</li>
<li>sharp back pain just below ribs</li>
<li>stomach pain</li>
<li>swelling of the face, ankles, or hands</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Pale skin</li>
<li>trouble breathing</li>
<li>unusual bleeding or bruising</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Back pain</li>
<li>fast heartbeat</li>
<li>swelling of the stomach</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of olsalazine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>diarrhea</li>
<li>loss of appetite</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Aching joints and muscles</li>
<li>acid or sour stomach</li>
<li>acne</li>
<li>anxiety</li>
<li>belching</li>
<li>bloated or full feeling</li>
<li>body aches or pain</li>
<li>bone pain</li>
<li>congestion</li>
<li>constipation</li>
<li>coughing</li>
<li>cramps</li>
<li>difficulty with moving</li>
<li>dizziness or drowsiness</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>indigestion</li>
<li>muscle pain or stiffness</li>
<li>passing of gas</li>
<li>shivering</li>
<li>sleeplessness</li>
<li>sneezing</li>
<li>stomach discomfort or upset</li>
<li>sweating</li>
<li>swelling or inflammation of the mouth</li>
<li>swollen joints</li>
<li>tender, swollen glands in the neck</li>
<li>trouble with sleeping</li>
<li>trouble with swallowing</li>
<li>unable to sleep</li>
<li>voice changes</li>
<li>weight loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Decreased interest in sexual intercourse</li>
<li>flushing, redness of the skin</li>
<li>hair loss or thinning of the hair</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>unusually warm skin</li>
</ul><p>
<!-- end oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to olsalazine: oral capsule</i></p><h3>General</h3><p>The most commonly reported side effects included diarrhea, abdominal pain, cramps, nausea, and headaches.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 17%), abdominal pain (up to 10.1%), cramps (10.1%)</p>
<p><b>Common</b> (1% to 10%): Bloating, heartburn, loose stools, nausea, rectal bleeding, stomatitis, upset stomach, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia</p>
<p><b>Frequency not reported</b>: Abdominal pain upper, diarrhea with dehydration, dry mouth, epigastric discomfort, exacerbation/flare in symptoms, flatulence, increased blood in stool, pancreatitis, rectal discomfort<sup>[Ref]</sup></p><p>Compared to patients given placebo, increased frequency and intensity of diarrhea was reported in patients given 500 mg orally 2 times a day who were also receiving pelvic radiation.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, lightheadedness, vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p>
<p><b>Frequency not reported</b>: Drowsiness, lethargy, peripheral neuropathy, tremors<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Itching, rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, photosensitivity/photosensitivity reaction, pruritus, urticaria</p>
<p><b>Frequency not reported</b>: Erythema, erythema nodosum<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia</p>
<p><b>Frequency not reported</b>: Irritability, mood swings<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, joint pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia</p>
<p><b>Frequency not reported</b>: Muscle cramps<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p>
<p><b>Frequency not reported</b>: Bronchospasm, interstitial lung/pulmonary disease, shortness of breath<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia</p>
<p><b>Postmarketing reports</b>: Elevated lactate dehydrogenase (LDH)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic enzyme increased</p>
<p><b>Rare</b> (0.01% to 0.1%): Granulomatous hepatitis, nonspecific, reactive hepatitis</p>
<p><b>Frequency not reported</b>: ALT elevated beyond normal range, AST elevated beyond normal range, hepatitis, increased bilirubin, mild cholestatic hepatitis</p>
<p><b>Postmarketing reports</b>: Cholestatic jaundice, cirrhosis, elevated alkaline phosphatase, elevated GGT, hepatic function changes, hepatocellular damage, hepatotoxicity, jaundice, liver failure, liver necrosis<sup>[Ref]</sup></p><p>Patients who developed granulomatous hepatitis, nonspecific, reactive hepatitis, or mild cholestatic hepatitis had complete recovery after treatment was withdrawn.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia</p>
<p><b>Frequency not reported</b>: Anemia, aplastic anemia, eosinophilia, granulocytopenia, hemolysis, hemolytic anemia, leukopenia, lymphopenia, neutropenia, pancytopenia, reticulocytosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>A patient developed thyroid disease 9 days after starting treatment and was given propranolol radioactive iodine; the patient then developed nausea and shortness of breath and died 5 days later with signs/symptoms of acute diffuse myocarditis.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Tachycardia</p>
<p><b>Frequency not reported</b>: Chest pains, heart block second degree, hot flashes, hypertension, myocarditis, orthostatic hypotension, palpitations, pericarditis, peripheral edema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Pyrexia</p>
<p><b>Frequency not reported</b>: Chills, fatigue, fever, miscellaneous side effects, rigors, tinnitus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Dysuria, frequency/urinary frequency, hematuria, impotence, menorrhagia, proteinuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, dry eyes, watery eyes<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Interstitial nephritis, nephrotic syndrome<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Angioneurotic edema<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Dipentum (olsalazine)." Meda Pharmaceuticals, Somerset, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about olsalazine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: 5-aminosalicylates</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Olsalazine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Dipentum</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Ankylosing Spondylitis</li>
<li>Ulcerative Colitis</li>
<li>Ulcerative Colitis, Active</li>
<li>Ulcerative Colitis, Maintenance</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to olsalazine: oral capsule</i></p><h3>General</h3><p>The most commonly reported side effects included diarrhea, abdominal pain, cramps, nausea, and headaches.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 17%), abdominal pain (up to 10.1%), cramps (10.1%)</p><p><b>Common</b> (1% to 10%): Bloating, heartburn, loose stools, nausea, rectal bleeding, stomatitis, upset stomach, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia</p><p><b>Frequency not reported</b>: Abdominal pain upper, diarrhea with dehydration, dry mouth, epigastric discomfort, exacerbation/flare in symptoms, flatulence, increased blood in stool, pancreatitis, rectal discomfort<sup>[Ref]</sup></p><p>Compared to patients given placebo, increased frequency and intensity of diarrhea was reported in patients given 500 mg orally 2 times a day who were also receiving pelvic radiation.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, lightheadedness, vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p><p><b>Frequency not reported</b>: Drowsiness, lethargy, peripheral neuropathy, tremors<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Itching, rash</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, photosensitivity/photosensitivity reaction, pruritus, urticaria</p><p><b>Frequency not reported</b>: Erythema, erythema nodosum<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia</p><p><b>Frequency not reported</b>: Irritability, mood swings<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, joint pain</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia</p><p><b>Frequency not reported</b>: Muscle cramps<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory infection</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Frequency not reported</b>: Bronchospasm, interstitial lung/pulmonary disease, shortness of breath<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia</p><p><b>Postmarketing reports</b>: Elevated lactate dehydrogenase (LDH)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic enzyme increased</p><p><b>Rare</b> (0.01% to 0.1%): Granulomatous hepatitis, nonspecific, reactive hepatitis</p><p><b>Frequency not reported</b>: ALT elevated beyond normal range, AST elevated beyond normal range, hepatitis, increased bilirubin, mild cholestatic hepatitis</p><p><b>Postmarketing reports</b>: Cholestatic jaundice, cirrhosis, elevated alkaline phosphatase, elevated GGT, hepatic function changes, hepatocellular damage, hepatotoxicity, jaundice, liver failure, liver necrosis<sup>[Ref]</sup></p><p>Patients who developed granulomatous hepatitis, nonspecific, reactive hepatitis, or mild cholestatic hepatitis had complete recovery after treatment was withdrawn.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia</p><p><b>Frequency not reported</b>: Anemia, aplastic anemia, eosinophilia, granulocytopenia, hemolysis, hemolytic anemia, leukopenia, lymphopenia, neutropenia, pancytopenia, reticulocytosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>A patient developed thyroid disease 9 days after starting treatment and was given propranolol radioactive iodine; the patient then developed nausea and shortness of breath and died 5 days later with signs/symptoms of acute diffuse myocarditis.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Tachycardia</p><p><b>Frequency not reported</b>: Chest pains, heart block second degree, hot flashes, hypertension, myocarditis, orthostatic hypotension, palpitations, pericarditis, peripheral edema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Pyrexia</p><p><b>Frequency not reported</b>: Chills, fatigue, fever, miscellaneous side effects, rigors, tinnitus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Dysuria, frequency/urinary frequency, hematuria, impotence, menorrhagia, proteinuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, dry eyes, watery eyes<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Interstitial nephritis, nephrotic syndrome<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Angioneurotic edema<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Dipentum (olsalazine)." Meda Pharmaceuticals, Somerset, NJ. </p><h2>More about olsalazine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: 5-aminosalicylates</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Olsalazine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Ankylosing Spondylitis</li>
<li>Ulcerative Colitis</li>
<li>Ulcerative Colitis, Active</li>
<li>Ulcerative Colitis, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>